NCT03382834: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03382834 |
|---|---|
| Title | Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 26, 2018 |
| Completion date | Dec. 4, 2018 |
| Required reporting date | Dec. 4, 2019, midnight |
| Actual reporting date | Dec. 2, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |